---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-021229"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:40:14.574711+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Augustine Chow retires from Imunon Board after 16 years

## Summary
- Augustine Chow, Ph.D., retired as Class I director effective June 14, 2023.
- He served on the Board since 2007 and was on Compensation and Audit Committees.
- Company did not nominate him for re-election due to age 70 and 16-year tenure.
- Retirement was not due to any disagreement with management or Board.

## SEC filing metadata
- accession: 0001493152-23-021229
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315223021229/0001493152-23-021229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315223021229/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-021229
- JSON: https://secwatch.observer/filing/0001493152-23-021229.json
- Plain text: https://secwatch.observer/filing/0001493152-23-021229.txt

## Key facts
- Executive change
  Augustine Chow retired as Class I Director at Imunon, Inc..
  - Action: retired
  - Role: Class I Director
  source text: On June 14, 2023, Augustine Chow, Ph.D., a Class I member of the Board of Directors (the “Board”) of Imunon, Inc. (the “Registrant”), retired from the Registrant’s Board upon conclusion of the 2023 Annual Meeting of Stockholders (the “Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315223021229/0001493152-23-021229-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.